Vimta Labs Limited
Get $10 bonus on your first $100 deposit for VIMTALABS.NS
Get $10 bonus on your first $100 deposit for VIMTALABS.NS
Vimta Labs Limited (VIMTALABS.NS) Stock Competitors & Peer Comparison
See (VIMTALABS.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VIMTALABS.NS | ₹408.95 | +0.18% | 18.3B | 24.58 | ₹16.64 | +0.24% |
| LALPATHLAB.BO | ₹1,329.30 | +0.71% | 222B | 41.99 | ₹31.66 | +0.95% |
| LALPATHLAB.NS | ₹1,328.70 | +0.39% | 221.9B | 42.02 | ₹31.62 | +0.95% |
| SAILIFE.NS | ₹959.95 | -1.73% | 203.3B | 60.68 | ₹15.82 | N/A |
| VIJAYA.NS | ₹897.05 | +1.41% | 92.1B | 57.84 | ₹15.51 | +0.22% |
| VIJAYA.BO | ₹895.85 | +1.40% | 92B | 57.76 | ₹15.51 | +0.22% |
| METROPOLIS.BO | ₹422.95 | -0.20% | 87.7B | 52.15 | ₹8.11 | +0.24% |
| METROPOLIS.NS | ₹421.75 | -0.59% | 87.4B | 52.26 | ₹8.07 | +0.24% |
| THYROCARE.BO | ₹366.15 | +1.33% | 19.4B | 42.04 | ₹8.71 | +2.55% |
| THYROCARE.NS | ₹366.00 | +1.10% | 19.4B | 42.02 | ₹8.71 | +2.55% |
Stock Comparison
VIMTALABS.NS vs LALPATHLAB.BO Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, LALPATHLAB.BO has a market cap of 222B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while LALPATHLAB.BO trades at ₹1,329.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas LALPATHLAB.BO's P/E ratio is 41.99. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to LALPATHLAB.BO's ROE of +0.24%. Regarding short-term risk, VIMTALABS.NS is more volatile compared to LALPATHLAB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for VIMTALABS.NS.Check LALPATHLAB.BO's competition here
VIMTALABS.NS vs LALPATHLAB.NS Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, LALPATHLAB.NS has a market cap of 221.9B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while LALPATHLAB.NS trades at ₹1,328.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas LALPATHLAB.NS's P/E ratio is 42.02. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to LALPATHLAB.NS's ROE of +0.24%. Regarding short-term risk, VIMTALABS.NS is less volatile compared to LALPATHLAB.NS. This indicates potentially lower risk in terms of short-term price fluctuations for VIMTALABS.NS.Check LALPATHLAB.NS's competition here
VIMTALABS.NS vs SAILIFE.NS Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, SAILIFE.NS has a market cap of 203.3B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while SAILIFE.NS trades at ₹959.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas SAILIFE.NS's P/E ratio is 60.68. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to SAILIFE.NS's ROE of +0.15%. Regarding short-term risk, VIMTALABS.NS is more volatile compared to SAILIFE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for VIMTALABS.NS.Check SAILIFE.NS's competition here
VIMTALABS.NS vs VIJAYA.NS Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, VIJAYA.NS has a market cap of 92.1B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while VIJAYA.NS trades at ₹897.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas VIJAYA.NS's P/E ratio is 57.84. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to VIJAYA.NS's ROE of +0.20%. Regarding short-term risk, VIMTALABS.NS is less volatile compared to VIJAYA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for VIMTALABS.NS.Check VIJAYA.NS's competition here
VIMTALABS.NS vs VIJAYA.BO Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, VIJAYA.BO has a market cap of 92B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while VIJAYA.BO trades at ₹895.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas VIJAYA.BO's P/E ratio is 57.76. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to VIJAYA.BO's ROE of +0.20%. Regarding short-term risk, VIMTALABS.NS is less volatile compared to VIJAYA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for VIMTALABS.NS.Check VIJAYA.BO's competition here
VIMTALABS.NS vs METROPOLIS.BO Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, METROPOLIS.BO has a market cap of 87.7B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while METROPOLIS.BO trades at ₹422.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas METROPOLIS.BO's P/E ratio is 52.15. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to METROPOLIS.BO's ROE of +0.13%. Regarding short-term risk, VIMTALABS.NS is more volatile compared to METROPOLIS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for VIMTALABS.NS.Check METROPOLIS.BO's competition here
VIMTALABS.NS vs METROPOLIS.NS Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, METROPOLIS.NS has a market cap of 87.4B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while METROPOLIS.NS trades at ₹421.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas METROPOLIS.NS's P/E ratio is 52.26. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to METROPOLIS.NS's ROE of +0.13%. Regarding short-term risk, VIMTALABS.NS is more volatile compared to METROPOLIS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for VIMTALABS.NS.Check METROPOLIS.NS's competition here
VIMTALABS.NS vs THYROCARE.BO Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, THYROCARE.BO has a market cap of 19.4B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while THYROCARE.BO trades at ₹366.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas THYROCARE.BO's P/E ratio is 42.04. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to THYROCARE.BO's ROE of +0.26%. Regarding short-term risk, VIMTALABS.NS is more volatile compared to THYROCARE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for VIMTALABS.NS.Check THYROCARE.BO's competition here
VIMTALABS.NS vs THYROCARE.NS Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, THYROCARE.NS has a market cap of 19.4B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while THYROCARE.NS trades at ₹366.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas THYROCARE.NS's P/E ratio is 42.02. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to THYROCARE.NS's ROE of +0.26%. Regarding short-term risk, VIMTALABS.NS is more volatile compared to THYROCARE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for VIMTALABS.NS.Check THYROCARE.NS's competition here
VIMTALABS.NS vs VIMTALABS.BO Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, VIMTALABS.BO has a market cap of 18.3B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while VIMTALABS.BO trades at ₹409.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas VIMTALABS.BO's P/E ratio is 24.65. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to VIMTALABS.BO's ROE of +0.20%. Regarding short-term risk, VIMTALABS.NS is less volatile compared to VIMTALABS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for VIMTALABS.NS.Check VIMTALABS.BO's competition here
VIMTALABS.NS vs KRSNAA.NS Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, KRSNAA.NS has a market cap of 17.9B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while KRSNAA.NS trades at ₹550.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas KRSNAA.NS's P/E ratio is 22.49. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to KRSNAA.NS's ROE of +0.09%. Regarding short-term risk, VIMTALABS.NS is more volatile compared to KRSNAA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for VIMTALABS.NS.Check KRSNAA.NS's competition here
VIMTALABS.NS vs KRSNAA.BO Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, KRSNAA.BO has a market cap of 17.8B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while KRSNAA.BO trades at ₹548.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas KRSNAA.BO's P/E ratio is 22.39. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to KRSNAA.BO's ROE of +0.09%. Regarding short-term risk, VIMTALABS.NS is more volatile compared to KRSNAA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for VIMTALABS.NS.Check KRSNAA.BO's competition here
VIMTALABS.NS vs SURAKSHA.NS Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, SURAKSHA.NS has a market cap of 12.8B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while SURAKSHA.NS trades at ₹244.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas SURAKSHA.NS's P/E ratio is 39.20. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to SURAKSHA.NS's ROE of +0.16%. Regarding short-term risk, VIMTALABS.NS is more volatile compared to SURAKSHA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for VIMTALABS.NS.Check SURAKSHA.NS's competition here
VIMTALABS.NS vs SURAKSHA.BO Comparison April 2026
VIMTALABS.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIMTALABS.NS stands at 18.3B. In comparison, SURAKSHA.BO has a market cap of 12.7B. Regarding current trading prices, VIMTALABS.NS is priced at ₹408.95, while SURAKSHA.BO trades at ₹244.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIMTALABS.NS currently has a P/E ratio of 24.58, whereas SURAKSHA.BO's P/E ratio is 39.12. In terms of profitability, VIMTALABS.NS's ROE is +0.20%, compared to SURAKSHA.BO's ROE of +0.16%. Regarding short-term risk, VIMTALABS.NS is more volatile compared to SURAKSHA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for VIMTALABS.NS.Check SURAKSHA.BO's competition here